Northwire Canada EditionFriday, July 10, 2026
Northwire
FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.35 +7.5% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.28 −2.3% SGZ 0.045 +0.0% S 0.135 +12.5% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% EMPR 0.840 +2.4% SAGA 0.480 +0.0% ABX 51.59 −1.2% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.35 +7.5% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.28 −2.3% SGZ 0.045 +0.0% S 0.135 +12.5% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% EMPR 0.840 +2.4% SAGA 0.480 +0.0% ABX 51.59 −1.2%
Financings Routine −

iFabric Corp. Announces Closing of $28 Million Bought Deal Offering

iFabric Closes $28M Bought Deal at a Discount as Revenue Surges 288% on Medical Scrubs and Footwear Boom

Executive Summary
  • iFabric Corp. closed a previously announced upsized bought deal treasury and secondary offering on June 5, 2026.
  • The company raised $23.0 million in gross proceeds from the treasury portion, while selling shareholders Hylton Karon and Susan Karon raised $5.0 million.
  • Total aggregate gross proceeds reached $28.0 million, with the underwriters fully exercising their 15% over-allotment option.
  • Issue price was set at $3.70 per share.
  • Net proceeds are designated for working capital and general corporate purposes.
  • The offering increased the total shares outstanding from approximately 30.3 million to roughly 37.9 million.
Material Impact
  • The financing is a routine execution of a previously announced capital raise, but the execution details carry negative weight.
  • The $3.70 issue price represents a ~10% discount to the recent trading range ($4.09-$4.99), indicating immediate dilution for existing shareholders.
  • The secondary portion of the offering ($5.0 million) was sold by the controlling shareholders (Karon family), reducing their stake from ~63.3% to ~50.0%. While still controlling, insider selling during a price run-up is a negative sentiment signal.
  • The capital raise is fundamentally necessary given the company's rapid revenue scaling, but it highlights the cash-intensive nature of the business model.
  • The news does not introduce new operational catalysts or strategic shifts; it is purely a balance sheet management event.
IFA · Price
Company Overview
  • iFabric Corp. develops and licenses advanced textile technologies, primarily through its subsidiary Intelligent Fabric Technologies (North America) Inc. (IFTNA).
  • Flagship Project: The PROTX2® antimicrobial and ecoPEL® durable-water-repellent technologies integrated into medical apparel (scrubs) and footwear.
  • Commercial Execution: Successfully scaled clinically validated scrubs programs with major retailers including Walmart (US) and Costco (Canada). Expanded into footwear via a Roots® branded program and intimate apparel via the owned Nudish™ brand following the Maidenform® license expiry.
  • Growth Drivers: Rapid expansion of healthcare apparel, category expansion into footwear and bedding, and transition from royalty-bearing licenses to higher-margin owned brands.
Read the original news release →

More from IFABRIC CORP. J